Recent meeting highlights emerging use of OCT in dermatology

Recognizing that optical coherence tomography (OCT) technology is heading towards general clinical use, the 1st International Optical Coherence Tomography User Meeting, chaired by Prof. Julia Welzel, chief physician at the Augsburg Hospital Department of Dermatology (Augsburg, Germany), showed attendees how OCT technology has advanced in recent years to the point where it is today.

Held during the 20th Congress of the European Academy of Dermatology and Venereology (EADV Congress; Lisbon, Portugal; October 20–24, 2011) and hosted by Michelson Diagnostics, the meeting brought together a group of clinicians from dermatology and rheumatology to share their recent clinical experience using OCT.

Attendees from Europe and the U.S. discussed a range of topics, including:

● Histological correlates of skin cancer using OCT: Dr. Katie Lacy and Dr. Andy Coleman, Guys and St. Thomas’ NHS Trust, London, England;
● New indications of OCT in Dermatology: Prof. Joachim Fluhr, Monica Kuck, and Prof. Juergen Lademann, Charité Hospital, Berlin, Germany;
● OCT Used for Monitoring of PDT Treatment of Superficial BCC: Prof. Gregor Jemec, Dr. Mette Mogensen, and Christina Banzhaf, Roskilde, Denmark;
● OCT imaging of nails and bullous diseases; Dr. Mette Mogensen, Prof. Gregor Jemec, and Christina Banzhaf, Roskilde, Denmark; and
● OCT in psoriasis and inflammatory arthritis; Dr. Zoe Ash and Prof. Dennis McGonagle, University of Leeds, Leeds, England.

Attendees agreed on the importance of future clinical work and collaboration in moving OCT from a research device to an imaging tool for routine clinical use in dermatology.

For more information or to obtain copies of presentations, please contact Welzel at [email protected] or Dr. Gordon McKenzie at [email protected].

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!